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A B S T R A C T
A general model useful to assess the applicability, in terms of safety and efficiency, of nanosilver sols in real
applications was developed. This led to the definition of an operative parameter, named Quality Index (QI), able
to rank the capacity of the samples to be applied effectively in safe concentration ranges on the basis of the mere
knowledge of the toxicological and antibacterial limits of the samples and of the fraction of silver ions (Ag+)
with respect the total silver in the samples and in the samples after application. The new approach was applied to
three nanosilver formulations to be used as antibacterial agents on tile surfaces, differing, essentially, for the
relative amount of silver ions and silver nanoparticles (Ag NPs): i) a (diluted) commercial sample (Ag1); ii) a
sample arising from the latter after an ultrafiltration treatment applied as remediation strategy (Ag31); and iii) a
sample synthesized at lab scale in controlled conditions (AgL). Such sols were characterized with in vitro toxicity
and antibacterial tests to collect the inputs required by the model. A general rationale to classify partially soluble
nanomaterials, exploitable in antibacterial applications, was thus introduced, opening a new perspective toward
the promotion of a safer by-design management of nanomaterials.
1. Introduction
Silver-based materials have been broadly used from long times in
different applications as photography and wound treatments, as well as
pigments, conductive/antistatic composites, catalysts, and biocides
(Lara, 2011; Nowack et al., 2011). Colloidal silver sols (suspensions of
silver nanoparticles, Ag NPs) have been commercialized for health and
medical reasons since the early twentieth century and at present they
are marketed as a dietary supplement and alternative medicine cure-all
(Seltenrich, 2013). Nevertheless, improved capabilities in nanoscience
and nanoparticle synthesis and engineering justify the novel/revived
attention on Ag NPs for antimicrobial applications (Woodrow Wilson
International Center for Scholars, 2013) with an estimated amount of
about 320 tons/year produced and used worldwide.
The mechanisms by which Ag NPs exert toxicity and, consequently,
antimicrobial effects, are not fully understood (Behra et al., 2013; Huk
et al., 2014; McShan et al., 2014; Reidy et al., 2013) but it is commonly
accepted that the release of silver ions (Ag+) represents the primary
mechanism of antibacterial action, with a negligible particle-specific
activity (Ivask et al., 2014a; Ma et al., 2012; Wijnhoven et al., 2009; Xiu
et al., 2012). As extensively reviewed by Liu and coworkers (Liu et al.,
2010), the majority of silver ions comes from oxidation of the zer-
ovalent metallic particle, typically by reaction with dissolved oxygen
(O2), mediated by protons and other components in the surrounding
fluid phase. Nevertheless, some unreacted silver ions can remain after
sol-gel synthesis, increasing the concentration of dissolved ions, and, as
a consequence, the antibacterial activity of the sample.
At the base of the ion-based toxicity pathway there is a strong in-
teraction with respiratory and transport proteins, due to the high affi-
nity of silver ions with thiol groups present in the cysteine residues of
those proteins (Marambio-Jones and Hoek, 2010). The hypothesized
role of the Ag NPs is both to generate a sustained flux of Ag+ ions from
their surfaces and to transport and let available active Ag+ ions to
sensitive biological targets on cell membranes or within cells, following
particle attachment or endocytosis, respectively. This could justify
many discrepancies found in literature between “silver ions” and
“particle-specific” toxicity/antibacterial mechanisms (Lubick, 2008).
Studies supporting a particle-specific antibacterial activity (Gunawan
et al., 2009; Ivask et al., 2012; Jin et al., 2010; Lok et al., 2006;
McQuillan et al., 2012; Navarro et al., 2008; Pal et al., 2007) are, in
fact, based on the lower toxicant reactivity of Ag+ ion solutions in
comparison to colloidal silver samples containing an equivalent amount
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of dissolved Ag+ ions. However the effect could be explained by con-
sidering not different toxicity pathways, but an increased bioavail-
ability of Ag+ ions to bacterial cells, depending on their release and
transport in aqueous phases from the Ag NPs surfaces (Ivask et al.,
2014a, 2014b).
In order to definitively overcome the confusion arising when solu-
bility of Ag NPs is discussed and, at the same time, to take into con-
sideration that the biological reactivity is related to the coexistence of
silver nanoparticles and silver ions, it is necessary to understand that Ag
NPs in their metallic form (noble metal) are totally insoluble and che-
mically inert, but when they come in touch with water, under aerobic
conditions, their surface is oxidized with the creation of a silver oxide
(Ag2O)/silver hydroxide (AgOH) layer and the consequent release of
silver ions. The solubility of the Ag2O/AgOH layer depends on ther-
modynamic parameters (pH, temperature), but also on kinetic factors
due to the non-stoichiometry solubility, which is surface-dependent
property, being affected by surface area, presence of defects, particle
size and shape, presence of capping agents (Misra et al., 2012). If only
the release mechanism was considered, no differences in the anti-
bacterial activity should be expected once samples were normalized for
the content of Ag+ ions in solution. As this does not occur, it is ne-
cessary to take into account also the contribution of the NPs. In order to
explain the combined toxic effects of silver ions and particles, it is ne-
cessary to change paradigm and to think in terms of different bioa-
vailability of Ag+ ions with respect to the cells (Navarro et al., 2015). In
fact, they will act differently depending if they are free in the electro-
lyte solution outside the cells, if they are adsorbed on Ag NP surfaces, or
if they are released from the Ag NP surfaces into the intracellular en-
vironment once penetrated through a Trojan-horse pathway (Bermejo-
Nogales et al., 2016; Gliga et al., 2014; Ivask et al., 2014b) as sche-
matized in Fig. 1.
Considering the extremely complex equilibrium speciation and
chemical pathways that lead Ag+ ions to react with biological targets,
the control of the content of Ag+ ions and of their distribution/avail-
ability within the biological matrix is, for sure, the main challenging
objective to control Ag NP hazardous properties. In this context, some
design strategies, acting on surface chemistry of the nanoparticles or on
their nano-structuring, allow to control the reactivity of Ag+ ions (i.e.,
their adverse effects against biological targets: both cytotoxicity and
antibacteride) and, at the same time, to preserve the toxicant action at
the base of antibacterial activity.
In this work three nanosilver sols, produced starting from the same
sol-gel synthesis route and differing only for the content of Ag+ ions
with respect to the total silver present in the sols in whatever form (NP
or ion) have been characterized in terms of decrease in cell viability
(IC50) and antibacterial performance (MIC99) after an industrially re-
levant application (spray deposition as antibacterial coating on ceramic
tile surfaces). The half maximal inhibitory concentration (IC50) and the
lowest concentration of Ag NPs that inhibits the visible growth of a
microorganism after overnight incubation – the minimum inhibitory
concentration (MIC) – have been measured and expressed in terms of
Ag+ dose, in order to allow a direct comparison with AgNO3 solutions.
It was thus possible to verify if silver nanosol reactivity was only Ag+
dependent or if there was a specific Ag NP activity. Such data have been
used to illustrate a general rationale to classify silver colloidal samples
as potential antibacterial agents, in relation with the conditions for
their safe use. In particular from the Ag+ ion doses and dilutions ne-
cessary to keep the Ag+ ion concentration lower than IC50 but higher
than MIC, it was possible define and calculate the Quality Index (QI),
that gives indications about the capacity of the sample to be applied as
antibacterial agent in a safe concentration range developing a general
approach for the safe design and management of partially soluble na-
nomaterials. The suggested new approach is illustrated, and the Quality
Index evaluated, on the basis of in vitro toxicity data, but in principle it
could be also applied by using in vivo toxicity or ecotoxicological data
and no (or low) observed adverse effect concentration (NOAEC or
LOAEC) or predicted no effect concentration (PNEC) as reference values
(Borm et al., 2006). The information generated in these cases would be
more realistic and also closer to the expectations of the European reg-
ulation for biocides that currently imposes important limitations to the
approaches based on in vitro data.
2. Materials and methods
2.1. Materials
A commercial silver nanosol, provided by Colorobbia Italia SpA
(4 wt% silver concentration), investigated also by NanoValid con-
sortium as reported by Jemec and co-workers (Jemec et al., 2016) and
patented in 2010, was diluted with Milli-Q water down to 1 wt%, in
order to avoid possible gelations during sample treatment, resulting in a
sol called Ag1.
Starting from such a diluted sol, an ultrafiltrated sample (Ag31) was
obtained by applying a series of ultrafiltrations by using the con-
servative Stirred Cell (SC) apparatus, (Merck Millipore) using a 100 kDa
polyethersulfone membrane disc and recovering at each step both Ag
Fig. 1. Chemical pathways leading Ag+ ions to react with a biological target.
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NPs-rich supernatant (ultrafiltered sol) and Ag+ ions solution permeate
(filtered solution). All the volume of the samples was filtered in the
stirred cell. The final total concentration of the purified Ag31 sample is
0.44 wt%.
Synthesized silver nanosol (AgL) at 0.5 wt% was obtained by sol-gel
synthesis using at lab scale level the same reducing (glucose) and
complexing (polyvinylpyrrolidone) agents, with the same stoichiometry
ratio, as used at industrial level for the synthesis of the commercial
patented sample (http://google.com/patents/WO2010100107A2,
n.d.).
AgNO3 solutions were used as benchmark material for toxicity ex-
periments. Dulbecco's modified Eagle's medium (DMEM) and Fetal
Bovine Serum (FBS) were from Euroclone SpA (Pero, Milan, Italy).
Bovine Serum Albumin (BSA) was from Sigma-Aldrich, Milan, Italy.
2.2. Size and zeta potential analysis
Hydrodynamic diameter and zeta potential of the Ag NPs in the
three nanosilver sols after dilution in Milli-Q water and DMEM medium
at 128 μg/mL of total silver concentration, were evaluated with a
Zetasizer Nano ZSP (model ZEN5600, Malvern Instruments, UK).
Hydrodynamic diameters were obtained from Dynamic Light Scattering
(DLS) data, setting the measurements in back-scattering mode with a
detection angle of 173°. After a 2min temperature equilibration step,
1 mL of sample volume was subjected to three consecutive measure-
ments performed at 25 °C, and particle size distributions by intensity
were obtained by averaging these measurements.
Zeta potential measurements were performed at 25 °C by
Electrophoretic Light Scattering (ELS) technique. Smoluchowski equa-
tion was applied to convert the electrophoretic mobility to zeta po-
tential. After a 2min temperature equilibration step, samples under-
went three measurements delayed of 120 s, and zeta potential was
obtained by averaging these measurements. Before and after zeta po-
tential analyses, a size measurement was performed to check that the
hydrodynamic diameter had not changed, i.e. that neither aggregation/
dissolution phenomena had occurred.
Morphological analysis was carried out using a High Resolution
(HR) Transmission Electron Microscopy (TEM) in JEOL JEM-2100F
multipurpose with a field emission source operating between 80 and
200 kV. Agglomeration factor was calculated by dividing DLS mean
diameter for TEM derived diameter.
2.3. Determination of the silver ionic ratios (Ag+/Ag)
The as prepared samples closed and wrapped in aluminum foil al-
lowed to equilibrate with ambient air for at least 3 days after pre-
paration, in order to achieve the stationary equilibrium. The amount of
Ag+ ions with respect the total amount of silver, ΩAg+(0), was de-
termined measuring the concentration of total silver in the sols by X-ray
Fluorescence (XRF) (Panalytical Axios Advanced, NL) and the con-
centration of silver ions by Atomic Absorption Spectroscopy (AAS)
(Perkin Elmer, USA) in the permeates, once separating the ions from
solid particles, through an ultrafiltration membrane, as reported also by
Jemec et al. 2016 (Jemec et al., 2016). We used Ultra Centrifugal Filter
(UCF) units (Amicon Ultra-15, 10 kDa, Millipore) for the samples Ag31
and AgL and Stirred Cell apparatus for the sample Ag1, assuming that
the ultrafiltration allows to separate completely the ionic fraction from
the solid one (see Electronic Supplementary Information – Section B).
Optimal ultrafiltration conditions for UCF were obtained with starting
volume sample of 13mL, a relative centrifugal field (RCF) of 3520g
(corresponding to 5000 rpm for the centrifuge used) and spin time of
30min.
In order to remove the excess of ions and establishing the amount of
ions leached at equilibrium the samples were subjected to repeated
ultrafiltration steps in the UCF units (see Fig. S2 – Electronic
Supplementary Materials); the filtered liquid was replaced with the
same volume of fresh Milli-Q water and the resulting sol left to equi-
librate for 24 h. This treatment was repeated several times till the
concentration of silver ions in the permeates reached an asymptotic
value. Assuming that the washing step occurring during the application
of the sols on the tile surfaces can be approximated by the first ultra-
filtration step, the silver ion fraction in the sols after application,
ΩAg+(3) has been approximated with the concentration of silver mea-
sured in permeates.
2.4. Dispersion of nanosilver sols within biological media
Nanosilver sols were first diluted in a 0.05 wt% solution of Bovine
Serum Albumin (BSA) in Phosphate Buffered Saline (PBS) without
calcium and magnesium, in order to obtain the more concentrated
100× stock suspension with Ag dose of 12.8 mg/mL (corresponding to
8mg/cm2 for a well of 96-well trays considering a filling volume of
200 μL). This stock was then diluted in 0.05 wt% BSA in PBS to obtain
the other 100× stock suspensions. All the stocks were then vortexed for
30 s, sonicated for 15min, re-vortexed for 30 s and finally dispersed in
complete growth medium (Dulbecco's modified Eagle's medium
(DMEM)+10wt% of Fetal Bovine Serum (FBS)).
2.5. Cells and experimental treatments
Mouse peritoneal monocyte-macrophage cells (Raw 264.7 line)
were obtained from the Istituto Zooprofilattico della Lombardia e
dell'Emilia (Brescia, Italy). Raw 264.7 cells were cultured in DMEM
supplemented with 10wt% FBS, 4mM glutamine, streptomycin
(100 μg/mL) and penicillin (100 U/mL). Cells were routinely cultured
in 10-cm diameter dishes (Falcon™ 353,003, Corning, New York, NY
(USA)), maintained in a humidified atmosphere of 5% CO2 in air. For
cytotoxicity tests, cells were seeded in complete growth medium
(DMEM+10% FBS) in 96-well multiwell plates (Falcon™ 353072), at a
density of 30× 103 cells/well. 24 h after cell seeding, the complete
growth medium was replaced with fresh medium supplemented with
Ag NPs prepared at different doses from the 100× stocks at 128mg/L.
Doses of NPs were adjusted in order to obtain silver concentrations per
unit of surface ranging from 0.3125 μg/cm2 to 80 μg/cm2 (corre-
sponding to a range from 0.5 to 128 μg/mL). In all the experiments,
vehicle (0.05 wt% BSA in PBS) was added to the control.
2.6. Cytotoxicity tests to determine the in vitro toxicity limit (IC50)
Cell viability was assessed with the indicator resazurin, a non-
fluorescent molecule which is converted by intracellular enzymes in the
fluorescent compound resorufin (λem=572 nm). After 24 h of in-
cubation in presence of Ag NPs, cell viability was tested replacing
medium with a solution of resazurin (44 μM) in serum-free medium.
After 20min, fluorescence was measured at 572 nm with a multimode
plate reader Perkin Elmer Enspire (Waltham, Massachussets, USA).
Since nanomaterials could interfere with cytotoxicity tests, a pre-
liminary experiment was performed Ag NP preparations (80 μg/cm2 of
Ag1 and Ag31) with resazurin (44mM) in the absence of cells or with
cells incubated for 20min in a medium containing resazurin (44mM)
and then measuring fluorescence. In either case, there was no difference
in the fluorescence signal compared with samples incubated without
NPs. Dose-response curves have been calculated with a GraphPad™
software, version 5.0 and the half maximal inhibitory concentration IC50
parameter evaluated.
2.7. Antibacterial tests to determine the antibacterial limit (MIC99)
Antibacterial activity against Escherichia coli was selected as mate-
rial functional property to be assessed. Escherichia coli strain ATCC8739
was chosen as model microorganism for inactivation experiments. For
the antibacterial activity assay, each sample (Ag1, Ag31, AgL and
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AgNO3 as comparison) was subsequently diluted in KH2PO4 buffered
solution (achieved diluting 5mL of buffer at pH 7 in 800mL of distilled
water), producing 10 test tubes with concentrations ranging from
50 μg/mL to 0.005 μg/mL. 1mL of inoculum containing
1.5–3.0×105 CFU/mL of bacterial was added to 9mL of the previously
prepared Ag diluted sols. The resulting systems were incubated at room
temperature and kept under stirring for 1 h. Then 1mL from each in-
cubated tube was withdrawn and added to test tubes containing 9mL of
a phosphate buffer solution. Finally 1mL from each prepared test tube
was inoculated in a plate culture agar, incubated at 37 °C and after 24 h
the viable cell count was performed from which the antibacterial limit
MIC99 was obtained. Three independent experiments were repeated for
each sample.
3. Theory and calculation
3.1. Quality Index
In order to find conditions for a fast evaluation of the biological
reactivity of nanosilver sols and to obtain useful information for their
safe and effective application as antibacterial coating agents, both
toxicity and antibacterial properties should be considered and related to
the sample physicochemical properties. Let us consider an aqueous
nanosilver sol to be applied as antibacterial agent on a ceramic tile
surface. In order to make the process safe and effective, such a sol has to
be non-toxic and antibacterial, respectively. The first condition (non-
toxicity) is satisfied if the following inequality is verified:
<+ +ω ωAg AgTox0( ) (1)
where ωAg+(0) is the mass fraction of silver ions in the sol and ωAg+Tox
is, in the present model, the in vitro toxicity limit (e.g., the IC50). If such
condition is not satisfied, it is necessary to treat the starting sol in some
way in order to reduce the silver ion concentration below the safety
limit. The easiest way to do this is to dilute the sol with deionized water
till the mass fraction of silver ions in the resulting sol, ωAg+(1), satisfies
the inequality:
<+ +ω ωAg AgTox1( ) (2)
Fig. 2 shows the dilution step, wherem0 and ωAg(0)are the total mass
and the mass fraction of silver in the starting sol, m1 and ωAg(1) are the
total mass and the mass fraction of silver in the resulting sol after di-
lution and mWD is the mass of water of dilution to add.
Let us suppose that a known mass m2 (<m1) of the diluted sol at
concentration ωAg(1) is then applied by spray-gun technique on a
ceramic tile surface. After spraying, the process foresees a washing
treatment of the surface with a known amount of water (mw). This
further treatment will remove part of the silver from the surface (cur-
rent 4) leaving on the surface a mass of sprayed sol m3 with a mass
fraction of silver ωAg(3) (Fig.3).
The second condition (antibacterial activity) is satisfied if the mass
fraction of silver ions in the sol after the application ωAg+(3) is higher
than the antibacterial limit ωAg+AntiB (e.g., the MIC99):
>+ +ω ωAg AgAntiB3( ) (3)
So, the upper and lower limits of the amount of diluting water to
add (mwD) to a given starting sol at concentration ωAg(0), to satisfy both
the condition were established (Eq. (4)):
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where ΩAg+(0) and ΩAg+(3) are the mass fraction of silver ions with re-
spect to the total amount of silver in the starting sol and in the sol
remained on the surface after application (spraying) and washing, re-
spectively (see Electronic Supplementary Information – Section D). In
order to find a general descriptor able to easily establish if a starting sol
could be made non-toxic remaining antibacterial and, more in general,
to assess the applicability of soluble nanomaterials whose biological
reactivity is driven by the availability of ionic form, Eq. (4) was re-
arranged as in Eq. (5):
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and a dimensionless parameter, named Quality Index (QI), defined as
the ratio between the upper and lower limits established by Eq. (5), was
introduced:
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Thus, it was possible to find a general criterion to establish if a
starting sol could be made non-toxic remaining antibacterial. If QI is
higher than 1 (QI≥ 1), a safe and effective sol can be obtained, while
this is not possible when (QI < 1). When QI= 1, the range collapses in
a point. The larger is the amplitude of the range and easier is to satisfy
both conditions. The quality of the starting sol is considered better
when this parameter assumes high values, and, for this reason, the
parameter was named Quality Index. The more interesting aspect is that
the QI depends only on four parameters, all experimentally measurable
and sample-dependent, except ΩAg+(3) that is also process-dependent:
• In vitro toxicity limit, ωAg+Tox;
• Antibacterial limit, ωAg+AntiB;
• Mass fraction of silver ions with respect the total amount of silver in
the starting sol,ΩAg+(0);
• Mass fraction of silver ions with respect to the total amount of silver
in the sol remained on the surface after washing, ΩAg+(3),
but it does not depend on the starting concentration of silver (ωAg(0)).
This means that is not important the concentration of total silver in the
starting sol, but rather which is the distribution of silver between ions
and nanoparticles.
4. Results and discussion
4.1. Size and zeta potential analysis
Some colloidal properties of the commercial (diluted) pristine sol
(Ag1), of the modified through ultrafiltration sol (Ag31), and of the
synthesized at lab scale sol (AgL), as measured in Milli-Q water and in
the culture medium used for toxicological tests, are summarized in
Table 1.
The samples dispersed in Milli-Q water showed quite similar values
of pH, hydrodynamic diameter (dDLS), zeta potential (ζ) and agglom-
eration factor. The pH of samples diluted (1:100) in cell media is in
agreement with the pH of medium alone that is around 8. The hydro-
dynamic diameter of samples and so their agglomeration state in pro-
tein rich medium did not change significantly, because the expectedFig. 2. Dilution step of the starting nanosilver sol.
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increase of diameter, due to the surface adsorption of aminoacids and
proteins (bio-corona theory) (Lynch and Dawson, 2008) is masked by
the large amount of PVP surrounding nanoparticles that ensure an high
stability of the nanosols over time (all the considered samples did not
show in water any aggregation/sedimentation phenomena in one year
of storage). The particle size in bacterial test medium (KH2PO4 buffered
solution) was not reported because did not significantly change if
compared to water suspension. The negative zeta potential showed by
Ag NPs in Milli-Q water is likely due to the presence of gluconate an-
ions, deriving by the oxidation of glucose (used as reducing agent)
during the synthesis, which remain adsorbed onto the surface. The
transfer to biological media and the slight decrease of the zeta potential
value for all the samples confirms the formation of protein corona that
levels off values around−8mV in DMEM, in agreement with the values
expected by serum protein at the corresponding medium pH (Casals
et al., 2010).
4.2. Silver ionic ratios (Ag+/Ag) in sols, ΩAg+(0) and sols after application
ΩAg+
(3)
Most of the confusion arising when data on toxicity of different
nanosilver sols are compared is due to the absence of data on the
content of Ag+ ions in the sols or by the absence of a shared and clear
analytical method to get this information and to interpret data in a
sound way. By applying mass balances (see Electronic Supplementary
Information – Section B), it was possible to determine the fraction of
permeated Ag+ ions with respect the silver concentration in the starting
sol, thus establishing the amount of Ag+ ions available to exert toxicant
action (see Electronic Supplementary Information – Section B - Table
S1).
The mass fraction of silver ions is reported in Table 2. In order to
establish the content of Ag+ ions present at equilibrium, we performed
repeated ultrafiltration steps on sol Ag31 with the destructive UCF
method. The fraction of Ag+ ions decreases after each ultrafiltration
step, until it reached an asymptotic value of 0.08% (Table S1 – Mass
fractions of silver ions in the starting and ultrafiltrated sols), after 3 UFC
steps and a total duration of 72 h. This value is consistent with the
equilibrium data reported in literature for the PVP-stabilized 40 nm Ag
nanoparticles (0.14%) (Reidy et al., 2013). It should be noted that
commercial sols contain an excess of ions (Ag+/Ag content higher than
that at equilibrium), reflecting the capacity of these commercial sam-
ples to storage higher amount of Ag+ ions, likely un-reacted ions dis-
tributed between solution and solid surface. Otherwise the AgL sample,
being synthetized at lab-scale in more controlled conditions, showed a
concentration of Ag+ ions (about 0.10%) similar to the one found at the
equilibrium.
The Ag+/Ag total values (ΩAg+(0)) reported in Table 2 have been
measured at the original sample concentration. In order to investigate
the dependence of dissolution on concentration, we measured in pre-
vious works the Ag+/Ag total of all Ag samples at lower concentration
in a range consistent with biological tests and we did not find sig-
nificant deviations from the values here reported.
4.3. Effect of silver ionic ratio (Ag+/Ag) on cell viability
The effects of the different silver nanosols on cell viability were
assessed in cultures of Raw 264.7 murine macrophages with the re-
sazurin method (see Electronic Supplementary Information – Fig. S3).
Fig. 3. Application step: spraying and washing.
Table 1
pH, size, and zeta potential (ζ) of nanosilver sols dispersed in Milli-Q water and culture medium DMEM. Agglomeration factor for samples dispersed in Milli-Q water.
Sample dTEM (nm) Milli-Q water DMEM
pH dDLS (nm) ζ (mV) Aggl. factora pH dDLS (nm) ζ (mV) Aggl. factora
Ag1 24 ± 11 4.0 130 ± 2 −14.0 ± 0.2 5.4 7.9 131 ± 1 −7.5 ± 0.3 5.5
Ag31 15 ± 11 4.5 103b ± 1 −16.3 ± 0.4 6.9 8.0 114 ± 2 −8.6 ± 1.2 7.6
AgL 18 ± 7 4.5 114 ± 1 −10.4 ± 0.2 6.3 n.d.
n.d.= not determined.
a Agglomeration factor is calculated by dividing DLS mean diameter by TEM average diameter (calculated for 100 particles) (see Electronic Supplementary
Information – Section A).
b Bimodal size distribution; size of each peak and relative volume of the two populations are: Peak 1 at 140 nm (49 vol%) and Peak 2 at 20 nm (51 vol%).
Table 2
pH and Ag+/Ag mass ratio, ΩAg+(0), for the target sols.
pH ΩAg+(0)(wt%)
Ag1 2.4 55.00
Ag31 3.5 2.69
AgL 4.5 0.10
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Solutions of AgNO3, equivalent in terms of total silver with the nanosols
tested, were used for comparison. When expressed as total silver, the
IC50 values were essentially inversely correlated with the silver ionic
ratio (Ag+/Ag), with samples having the lower ratios exhibiting very
low cytotoxicity (Table 3). Conversely, when the IC50 is expressed on
the basis of the Ag+ ion concentration, the IC50 values for Ag1, Ag31
and AgNO3 were roughly comparable, while the IC50 of AgL was
markedly lower (see Electronic Supplementary Information – Section
C).
The last result suggests for AgL a key contribution of the nano-
particles to cytotoxicity, which in this sample are in large excess with
respect to the ions. Likely, the nanoparticles enhance the bioavailability
of Ag+ toward the target by means of a Trojan horse mode of action, as
schematized in Fig. 1.
4.4. Antibacterial activity
The antibacterial activity of the samples Ag1, Ag31, AgL and AgNO3
(as comparison) has been evaluated by assessing the percentage re-
duction of the bacterial cell number (Escherichia coli) for different Ag
doses (Table 4). Data confirm the high reactivity of nanosilver as an-
tibacterial agent at very low concentrations; in fact, with reference to
the total silver, the minimum inhibitory concentration (MIC99), corre-
sponding to the lowest concentration at which the samples show the
highest bacterial reduction (99%), ranges from few mg/L for AgL to
some μg/L for Ag1; in particular Ag1 showed 99% of bacterial inhibi-
tion for a concentration of 50 μg/L, while Ag31 and AgL much higher
values (440 and 4000 μg/L, respectively). However, if MIC99 is referred
to the silver ions concentration all the samples have MIC99 of the same
order of magnitude, as observed from the diagrams of Fig. 4 and from
data listed in Table 4.
Based on these results, AgL showed the same reactivity of AgNO3,
showing an antibacterial activity which seems dependent only by the
Ag+ concentration. Conversely, Ag31 and particularly Ag1 samples
Table 3
Effect of different silver preparations on cell viabilitya.
Sample Ag+/Ag
(wt%)
IC50 Total
silver
(mg/L)
Confidence
Interval (95%)
IC50 Ag+
ions
(mg/L)
Confidence
Interval (95%)
Ag1 55.00 4.66 4.11–5.28 2.56 2.26–2.90
Ag31 2.69 95.7 68.4–134 2.58 1.84–3.61
AgL 0.10 59.6 52.4–67.8 0.060 0.052–0.068
AgNO3 100.00 2.61 2.24–3.05 2.615 2.24–3.050
a For each sample, the IC50 values are obtained from data of two separate
experiments with four independent determinations each.
Table 4
MIC99 for different Ag nanosols and comparison with AgNO3 solution.
Sample MIC99 Total silver (μg/L) MIC99 Ag+ ions (μg/L)
Ag1 50 27.5
Ag31 440 11.9
AgL 4000 4.0
AgNO3 2.5 2.5
Fig. 4. Dose-response histograms of the bacterial depletion (Escherichia coli) as function of Ag+ concentration.
Table 5
Data used to identify the dilution ranges and calculate the QI.
ωAg+Tox ωAg+AntiB ΩAg+(0) ΩAg+(3) Upper limit Lower limit QI
(mg/L) (mg/L) (%) (%) for mwD/m0 for mwD/m0
Ag1 2.56 0.0275 55.00 2.69 4.60E+03 2.19E+03 2.11
Ag31 2.58 0.0119 2.69 0.34 1.28E+03 4.71E+01 26.76
AgL 0.06 0.0040 0.10 0.10 1.25E+03 8.23E+01 15.00
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seem to be less reactive in terms of Ag+ activity, so we can hypothesize
that in these cases some the Ag+ ions were not bioavailable for the
antibacterial action.
4.5. Quality Index
Using in vitro toxicity and antibacterial limits, calculated in the
previous paragraphs and reported in Table 5, it was possible to de-
termine for each sample a useful descriptor for its “safe” and “effective”
use identifying the dilution ranges, schematized also in Fig. 5. Thus, it
can easily viewed that sample Ag31, derived by pristine commercial
sample after ultrafiltration treatment, has the highest range of dilution
ratio and, therefore, the highest chance to be applied in a “safe” zone,
despite the low concentration of toxicant Ag+ ions that was expected to
decrease its antibacterial performances as well. Furthermore, AgL, ob-
tained at lab scale under more controlled conditions, improved the
quality of the commercial sample, despite its higher in vitro toxicity.
On the basis of the previous experimental data, the QI for the three
target nanosols was calculated, resulting to be about 2, 27 and 15 for
Ag1, Ag31 and AgL, respectively. Furthermore it should be stressed that
this model is valid also if in vitro toxicity limit is replaced by other
threshold value used to predict toxicity through different adverse out-
come pathway (Arts et al., 2016). Within this definition, all the samples
tested showed a Quality Index> 1, and, therefore, it was possible to
identify a ‘safe and active’ concentration range where samples resulted
below the toxicity limit but still antibacterial (Fig. 5).
Sample Ag31, simply derived from Ag1, removing after one ultra-
filtration treatment part of the excess of free ions is the most promising
one, while sample AgL, synthesized in laboratory under controlled
conditions, resulted better than the commercial one, suggesting stra-
tegies for a control of toxicity by preserving material functionalities for
antibacterial coating nanomaterials (safe-by-design approach).
5. Conclusions
Three different nanosilver sols, produced with the same sol-gel
synthesis pathway and, ultimately, differing only for the fraction of
silver ions with respect the total silver, were compared in terms of
decrease in cell viability (IC50), bacterial cell number reduction per-
centage and antibacterial performance with reference to an industrially
relevant application (deposition of antibacterial nanosilver coatings on
ceramic tile surfaces). Ag+/Ag ratio was calculated in water and it was
found that a diluted commercial sample (Ag1) presented a high and
unexpected content of Ag+ ions, around 50%. Ultrafiltration treatment
applied to Ag1 or a new synthesis, performed at lab scale following the
same procedure as industrial synthesis (AgL), strongly reduced the
amount of Ag+ ions and, thus, the toxic and antibacterial activities,
which were in all cases dependent on available Ag+ ion fraction. For
each sample dilution limits were calculated, which define a range of
concentrations where the sample can be applied under the IC50 con-
centration, but above MIC99, in order to be not toxic but still anti-
bacterial. A model was developed for assessing biological sample re-
activity in relation to specific applications. A general rationale to
classify silver colloidal samples and identify conditions for a safe use,
preserving the expected antibacterial activity, was presented. This led
to the definition of a Quality Index (QI), representative of the capacity
of the sample to be applied and exploited in a safe concentration range.
Thus, it was possible, for the first time, to develop a general approach
for the safe design and management of partially soluble nanomaterials,
exploited in antibacterial applications.
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